136 related articles for article (PubMed ID: 18676243)
21. [High level expression of 5-helix protein in HIV gp41 heptad repeat regions and its virus fusion-inhibiting activity].
Wang J; Pan X; Tien P; Liu S
Sheng Wu Gong Cheng Xue Bao; 2009 Mar; 25(3):435-40. PubMed ID: 19621587
[TBL] [Abstract][Full Text] [Related]
22. Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.
Golding H; Zaitseva M; de Rosny E; King LR; Manischewitz J; Sidorov I; Gorny MK; Zolla-Pazner S; Dimitrov DS; Weiss CD
J Virol; 2002 Jul; 76(13):6780-90. PubMed ID: 12050391
[TBL] [Abstract][Full Text] [Related]
23. Identification of a D-amino acid decapeptide HIV-1 entry inhibitor.
Boggiano C; Jiang S; Lu H; Zhao Q; Liu S; Binley J; Blondelle SE
Biochem Biophys Res Commun; 2006 Sep; 347(4):909-15. PubMed ID: 16854380
[TBL] [Abstract][Full Text] [Related]
24. Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1.
Debnath AK; Radigan L; Jiang S
J Med Chem; 1999 Aug; 42(17):3203-9. PubMed ID: 10464007
[TBL] [Abstract][Full Text] [Related]
25. Blocking HIV entry.
Buzko OV; Shokat KM
Nat Struct Biol; 1999 Oct; 6(10):906-8. PubMed ID: 10504719
[TBL] [Abstract][Full Text] [Related]
26. Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation.
Miyauchi K; Kozlov MM; Melikyan GB
PLoS Pathog; 2009 Sep; 5(9):e1000585. PubMed ID: 19763181
[TBL] [Abstract][Full Text] [Related]
27. Human erythrocyte glycolipids promote HIV-1 envelope glycoprotein-mediated fusion of CD4+ cells.
Puri A; Hug P; Muñoz-Barroso I; Blumenthal R
Biochem Biophys Res Commun; 1998 Jan; 242(1):219-25. PubMed ID: 9439639
[TBL] [Abstract][Full Text] [Related]
28. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.
Liu S; Lu H; Zhao Q; He Y; Niu J; Debnath AK; Wu S; Jiang S
Biochim Biophys Acta; 2005 May; 1723(1-3):270-81. PubMed ID: 15823507
[TBL] [Abstract][Full Text] [Related]
29. A homogeneous time-resolved fluorescence assay to identify inhibitors of HIV-1 fusion.
Smeulders L; Bunkens L; Vereycken I; Van Acker K; Holemans P; Gustin E; Van Loock M; Dams G
Methods Mol Biol; 2013; 1030():11-7. PubMed ID: 23821256
[TBL] [Abstract][Full Text] [Related]
30. Identification of the HIV-1 gp41 core-binding motif--HXXNPF.
Huang JH; Liu ZQ; Liu S; Jiang S; Chen YH
FEBS Lett; 2006 Sep; 580(20):4807-14. PubMed ID: 16904109
[TBL] [Abstract][Full Text] [Related]
31. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: implication for mode of action.
Lev N; Fridmann-Sirkis Y; Blank L; Bitler A; Epand RF; Epand RM; Shai Y
Biochemistry; 2009 Apr; 48(14):3166-75. PubMed ID: 19206186
[TBL] [Abstract][Full Text] [Related]
32. Discovery of small molecule fusion inhibitors targeting HIV-1 gp41.
Zhou G; Chu S
Curr Pharm Des; 2013; 19(10):1818-26. PubMed ID: 23092284
[TBL] [Abstract][Full Text] [Related]
33. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
Münch J; Ständker L; Adermann K; Schulz A; Schindler M; Chinnadurai R; Pöhlmann S; Chaipan C; Biet T; Peters T; Meyer B; Wilhelm D; Lu H; Jing W; Jiang S; Forssmann WG; Kirchhoff F
Cell; 2007 Apr; 129(2):263-75. PubMed ID: 17448989
[TBL] [Abstract][Full Text] [Related]
34. [Study of the mechanism of caffeoyl glucopyranoses in inhibiting HIV-1 entry using pseudotyped virus system].
Xia CL; Mao QC; Li RM; Chen ZP; Jiang SB; Jiang ZH; Liu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):720-3. PubMed ID: 20423834
[TBL] [Abstract][Full Text] [Related]
35. [Inhibition of HIV-1 mediated cell-cell fusion by saponin fraction from Psidium guajava leaf].
Mao QC; Zhou YC; Li RM; Hu YP; Liu SW; Li XJ
Zhong Yao Cai; 2010 Nov; 33(11):1751-4. PubMed ID: 21434438
[TBL] [Abstract][Full Text] [Related]
36. Artificial ion channel biosensor in human immunodeficiency virus gp41 drug sensing.
Hou Y; Gochin M
Anal Chem; 2008 Aug; 80(15):5924-9. PubMed ID: 18590277
[TBL] [Abstract][Full Text] [Related]
37. The mechanism by which molecules containing the HIV gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formation.
Huang JH; Yang HW; Liu S; Li J; Jiang S; Chen YH
Biochem J; 2007 May; 403(3):565-71. PubMed ID: 17223796
[TBL] [Abstract][Full Text] [Related]
38. Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation.
Gallo SA; Wang W; Rawat SS; Jung G; Waring AJ; Cole AM; Lu H; Yan X; Daly NL; Craik DJ; Jiang S; Lehrer RI; Blumenthal R
J Biol Chem; 2006 Jul; 281(27):18787-92. PubMed ID: 16648135
[TBL] [Abstract][Full Text] [Related]
39. Isolation of virus-cell fusion inhibitory components from Eugenia caryophyllata.
Kim HJ; Lee JS; Woo ER; Kim MK; Yang BS; Yu YG; Park H; Lee YS
Planta Med; 2001 Apr; 67(3):277-9. PubMed ID: 11345703
[TBL] [Abstract][Full Text] [Related]
40. Small molecule fusion inhibitors: design, synthesis and biological evaluation of (Z)-3-(5-(3-benzyl-4-oxo-2-thioxothiazolidinylidene)methyl)-N-(3-carboxy-4-hydroxy)phenyl-2,5-dimethylpyrroles and related derivatives targeting HIV-1 gp41.
He XY; Lu L; Qiu J; Zou P; Yu F; Jiang XK; Li L; Jiang S; Liu S; Xie L
Bioorg Med Chem; 2013 Dec; 21(23):7539-48. PubMed ID: 23673219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
